Cylene Pharmaceuticals Secures $15,635,924 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=03166fbe-6d44-4c5e-9ad0-00c890f0d385&Preview=1 -
Date
8/11/2011 -
Company Name
Cylene Pharmaceuticals -
Mailing Address
5820 Nancy Ridge Drive San Diego, CA 92121 -
Company Description
Cylene Pharmaceuticals, Inc. is a privately held pharmaceutical company dedicated to the discovery, development and commercialization of first-in-class small molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. -
Website
http://www.cylenepharma.com -
Transaction Type
Debt -
Transaction Amount
$15,635,924 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
